References
- Dimopoulos MA, Terpos E, Chanan-Khan A, . Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 2010; 28:4976–4984.
- Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991;324:1845–1851.
- Katzmann JA, Kyle RA, Benson J, . Screening panels for detection of monoclonal gammopathies. Clin Chem 2009;55:1517–1522.
- Vrana JA, Gamez JD, Madden BJ, . Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 2009;114:4957–4959.
- Leung N, Rajkumar SV. Renal manifestations of plasma cell disorders. Am J Kidney Dis 2007;50:155–165.
- Nasr SH, Satoskar A, Markowitz GS, . Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 2009; 20:2055–2064.
- Soares SM, Lager DJ, Leung N, . A proliferative glomerulonephritis secondary to a monoclonal IgA. Am J Kidney Dis 2006; 47:342–349.
- Sethi S, Zand L, Leung N, . Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 2010;5:770–782.
- Papanikolaou X, Barlogie B, Usmani SZ. Therapy-related myeloid malignancies in myeloma. Mediterr J Hematol Infect Dis 2011; 3:e2011047.
- Nishida Y, Iwama K, Yamakura M, . Renal Fanconi syndrome as a cause of chronic kidney disease in patients with monoclonal gammopathy of undetermined significance: partially reversed renal function by high-dose dexamethasone with bortezomib. Leuk Lymphoma 2012;53:1804–1806.
- Ma CX, Lacy MQ, Rompala JF, . Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma. Blood 2004;104:40–42.
- Mehrotra R, Chiu YW, Kalantar-Zadeh K, . Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011;171:110–118.
- Leung N, Lager DJ, Gertz MA, . Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis 2004;43:147–153.
- Czarnecki PG, Lager DJ, Leung N, . Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits. Kidney Int 2009; 75:420–427.
- Beijers AJ, Jongen JL, Vreugdenhil G. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Neth J Med 2012; 70:18–25.
- Rajkumar SV, Blood E. Lenalidomide and venous thrombosis in multiple myeloma. N Engl J Med 2006;354:2079–2080.
- Rajkumar SV. Thalidomide therapy and deep venous thrombosis in multiple myeloma. Mayo Clin Proc 2005;80:1549–1551.